1. Wilkinson CF Jr. Recurrent migrainoid headaches associated with
spontaneous hypoglycemia. Am J Med Sci 1949;218:209–12.
2. Dexter JD, Roberts J, Byer JA. The five hour glucose tolerance test
and effect of low sucrose diet in migraine. Headache 1978;18:91–4.
3. Grant EC. Food allergies and migraine. Lancet
1979;i:966–9.
4. Monro J, Brostoff J, Carini C, Zilkha K. Food allergy in migraine.
Lancet 1980;ii:1–4.
5. Egger J, Carter CM, Wilson J, et al. Is migraine food allergy? A
double-blind controlled trial of oligoantigenic diet treatment. Lancet
1983;ii:865–9.
6. Hughs EC, Gott PS, Weinstein RC, Binggeli R. Migraine: a diagnostic
test for etiology of food sensitivity by a nutritionally supported fast and confirmed by
long-term report. Ann Allergy 1985;55:28–32.
7. Egger J, Carter CM, Soothill JF, Wilson J. Oligoantigenic diet
treatment of children with epilepsy and migraine. J Pediatr 1989;114:51–8.
8. Brainard JB. Angiotensin and aldosterone elevation in salt-induced
migraine. Headache 1981;21:222–6.
9. Ratner D, Shoshani E, Dubnov B. Milk protein-free diet for nonseasonal
asthma and migraine in lactase-deficient patients. Isr J Med Sci
1983;19:806–9.
10. Hanington E. Preliminary report on tyramine headache. Br Med
J 1967;2:550–1.
11. Smith I, Kellow AH, Hanington E. A clinical and biochemical
correlation between tyramine and migraine headache. Headache 1970;10:43–51.
12. Perkine JE, Hartje J. Diet and migraine: a review of the literature.
J Am Diet Assoc 1983;83:459–63.
13. Koehler SM, Glaros A. The effect of aspartame on migraine headache.
Headache 1988;28:10–3.
14. Lipton RB, Newman LC, Solomon S. Aspartame and headache. N Engl J
Med 1988;318:1200–1.
15. Hasselmark L, Malmgren R, Hannerz J. Effect of a carbohydrate-rich
diet, low in protein-tryptophan, in classic and common migraine. Cephalalgia
1987;7:87–92.
16. Unge G, Malmgren R, Olsson P, et al. Effects of dietary
protein-tryptophan restriction upon 5-HT uptake by platelets and clinical symptoms in
migraine-like headache. Cephalalgia 1983;3:213–8.
17. Kangasniemi P, Falck B, Langvik V-A, Hyyppa MT. Levotryptophan
treatment in migraine. Headache 1978;18:161–6.
18. Gasbarrini A, De Luca A, Fiore G, et al. Beneficial effects of
Helicobacter pylori eradication on migraine. Hepatogastroenterology
1998;45:765–70.
19. Gallai V, Sarchielli P, Coata G, et al. Serum and salivary magnesium
levels in migraine. Results in a group of juvenile patients. Headache
1992;32:132–5.
20. Baker B. New research approach helps clarify magnesium/migraine link.
Family Pract News 1993;Aug 15:16.
21. Barbiroli B, Lodi R, Cortelli P, et al. Low brain free magnesium in
migraine and cluster headache: an interictal study by in vivo phosphorus magnetic resonance
spectroscopy on 86 patients. Cephalalgia 1997;17:254.
22. Mazzotta G, Sarchielli P, Alberti A, Gallai V. Intracellular Mg++
concentration and electromyographical ischemic test in juvenile headache. Cephalalgia
1999;19:802–9.
23. Weaver K. Magnesium and migraine. Headache 1990;30:168
[letter].
24. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with
oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind
randomized study. Cephalalgia 1996;16:257–63.
25. Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of
menstrual migraine: effects on intracellular magnesium. Headache
1991;31:298–301.
26. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the
prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia
1996;16:436–40.
27. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium
sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a
pilot study. Clin Sci 1995;89:633–6.
28. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a
prophylactic treatment of migraine: results of an open pilot study. Cephalalgia
1994;14:328–9.
29. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose
riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology
1998;50:466–70.
30. Schoenen J, Jacquy, Lenaerts M. High-dose riboflavin as a novel
prophylactic antimigraine therapy: results from a double-blind, randomized, placebo-controlled
trial. Cephalalgia 1997;17:244 [abstract].
31. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin,
magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache
2004;44:885–90.
32. van der Kuy PHM, Merkus FWHM, Lohman JJHM, ter Berg JWM, Hooymans PM.
Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot
study. Cephalalgia 2002;22:513–9.
33. Kimball RW, Friedman AP, Vallejo E. Effect of serotonin in migraine
patients. Neurology 1960;10:107–11.
34. Sicuteri F. The ingestion of serotonin precursors
(L-5-hydroxytryptophan and L-tryptophan) improves migraine headache. Headache
1973;13:19–22.
35. Titus F, Davalos A, Alom J, Codina A. 5-hydroxytryptophan versus
methysergide in the prophylaxis of migraine. Eur Neurol 1986;25:327–9.
36. Maissen CP, Ludin HP. Comparison of the effect of 5-hydroxytryptophan
and propranolol in the interval treatment of migraine . Schweizerische Medizinische
Wochenschrift /Journal Suisse de Medecine 1991;121:1585–90 [in German].
37. De Benedittis G, Massei R. 5-HT precursors in migraine prophylaxis: A
double-blind cross-over study with L-5-hydroxytryptophan versus placebo. Clin J Pain
1986;3:123–9.
38. Mathew NT. 5-hydroxytryptophan in the prophylaxis of migraine.
Headache 1978;18:111–3.
39. Bono G, Criscuoli M, Martignoni E, et al. Serotonin precursors in
migraine prophylaxis. Advances in Neurology 1982;33:357–63.
40. De Giorgis G, Miletto R, Iannuccelli M, et al. Headache in
association with sleep disorders in children: A psychodiagnostic evaluation and controlled
clinical study ñ L-5-HTP versus placebo. Drugs Exptl Clin Res
1987;13:425–33.
41. Santucci M, Cortelli P, Rossi PG, et al. L-5-Hydroxytryptophan versus
placebo in childhood migraine prophylaxis: a double-blind crossover study.
Cephalalgia 1986;6:155–7.
42. Magis D, Ambrosini A, Sandor P, et al. A randomized double-blind
placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache
2007;47:52–7.
43. McCarren T, Hitzemann R, Allen C, et al. Amelioration of severe
migraine by fish oil (omega-3) fatty acids. Am J Clin Nutr 1985;41:874
[abstract].
44. Glueck CJ, McCarren T, Hitzemann R, et al. Amelioration of severe
migraine with omega-3 fatty acids: a double-blind placebo controlled clinical trial. Am J
Clin Nutr 1986;43:710 [abstract].
45. Thys-Jacobs S. Vitamin D and calcium in menstrual migraine.
Headache 1994;34:544–6.
46. Thys-Jacobs S. Alleviation of migraines with therapeutic vitamin D
and calcium. Headache 1994;34:590–2.
47. Hershey AD, Powers SW, Vockell ALB, et al. Coenzyme Q10 deficiency
and response to supplementation in pediatric and adolescent migraine. Headache
2007;47:73–80.
48. Rozen TD, Oshinsky ML, Gebeline CA,, et al. Open label trial of
coenzyme Q10 as a migraine preventive. Cephalalgia 2002;22:137–41.
49. Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10
in migraine prophylaxis: a randomized controlled trial. Neurology
2005;64:713–5.
50. Gatto G, Caleri D, Michelacci S, Sicuteri F. Analgesizing effect of a
methyl donor (S-adenosylmethionine) in migraine: an open clinical trial. Int J Clin
Pharmacol Res 1986;6:15–7.
51. Claustrat B, Brun J, Geoffriau M, et al. Nocturnal plasma melatonin
profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia
1997;17:511–7 (discussion 487).
52. Nagtegaal JE, Smits MG, Swart AC, et al. Melatonin-responsive
headache in delayed sleep phase syndrome: preliminary observations. Headache
1998;38:303–7.
53. Diener HC, Rahlfs VW. Danesch U. The first placebo-controlled trial
of a special butterbur extract for the prevention of migraine: reanalysis of efficacy
criteria. Eur Neurol 2004;51:89–97.
54. Grossmann M, Schmidramsl H. An extract of Petasites hybridus is
effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther
2000;38:430–5.
55. Pothmann R, Danesch U. Migraine prevention in children and
adolescents: results of an open study with a special butterbur root extract. Headache
2005;45:196–203.
56. Lipton RB, Gobel H, Einhaupl KM, et al. Petasites hybridus
root (butterbur) is an effective preventive treatment for migraine. Neurology
2004;63:2240–4.
57. Volger BK, Pittler MH, Ernst E. Feverfew as a preventive treatment
for migraine: a systematic review. Cephalagia 1998;18:704–8.
58. Murphy JJ, Hepinstall S, Mitchell JR. Randomized double-blind placebo
controlled trial of feverfew in migraine prevention. Lancet 1988;2:189–92.
59. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as
prophylactic treatment of migraine. Br Med J (Clin Res Ed) 1985;291:569–73.
60. Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum
parthenium) as a prophylactic treatment for migraine: A double-blind placebo-controlled
study. Phytother Res 1997;11:508–11.
61. Diener HC, Pfaffenrath V, Schnitker J, et al. Efficacy and safety of
6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention - a randomized,
double-blind, multicentre, placebo-controlled study. Cephalalgia
2005;25:1031–41.
62. De Weerdt CJ, Bootsma HPR, Hendriks H. Herbal medicines in migraine
prevention. Phytomedicine 1996;3:225–30.
63. Awang DVC. Parthenolide: The demise of a facile theory of feverfew
activity. J Herbs Spices Medicinal Plants 1998;5:95–8.
64. Mustafa T, Srivastava KC. Ginger (Zingiber officinale) in
migraine headache. J Ethnopharmacol 1990;29:267–73.
65. Chung KF, McCusker M, Page CP, et al. Effect of a ginkgolide mixture
(BN 52063) in antagonising skin and platelet responses to platelet activating factor in man.
Lancet 1987;i:248–51.
66. Levy RL. Intranasal capsaicin for acute abortive treatment of
migraine without aura. Headache 1995;35:277 [letter].
67. Baischer W. Acupuncture in migraine: long-term outcome and predicting
factors. Headache 1995;35:472–4.
68. Boivie J, Brattberg G. Are there long lasting effects on migraine
headache after one series of acupuncture treatments? Am J Chin Med
1987;15:69–75.
69. Loh L, Nathan PW, Schott GD, Zilkha KJ. Acupuncture versus medical
treatment for migraine and muscle tension headaches. J Neurol Neurosurg Psychiatry
1984;47:333–7.
70. Spoerel WE, Varkey M, Leung CY. Acupuncture in chronic pain. Am J
Chin Med 1976;4:267–79.
71. Vincent CA. A controlled trial of the treatment of migraine by
acupuncture. Clin J Pain 1989;5:305–12.
72. Lenhard L, Waite PME. Acupuncture in the prophylactic treatment of
migraine headaches: pilot study. NZ Med J 1983;96:663–6.
73. Vincent CA. A controlled trial of the treatment of migraine by
acupuncture. Clin J Pain 1989;5:305–12.
74. Baischer W. Acupuncture in migraine: long-term outcome and predicting
factors. Headache 1995;35:472–4.
75. Cheng AC. The treatment of headaches employing acupuncture. Am J
Chin Med 1975;3:181–5.
76. Shuyuan G, Donglan Z, Yanguang X. A comparative study on the
treatment of migraine headache with combined distant and local acupuncture points versus
conventional drug therapy. Am J Acupuncture 1999;27:27–30.
77. Hesse J, Mogelvang B, Simonsen H. Acupuncture versus metoprolol in
migraine prophylaxis: a randomized trial of trigger point inactivation. J Intern Med
1994;235:451–6.
78. Ahmed HE, White PF, Craig WF, et al. Use of percutaneous electrical
nerve stimulation (PENS) in the short-term management of headache. Headache
2000;40:311–5.
79. Tuchin PJ. A case series of migraine changes following a manipulative
therapy trial. Australasian Chiropractic and Osteopathy 1997;6(3):85–91.
80. Vernon H, Steiman I, Hagino C. Cervicogenic dysfunction in muscle
contraction headache and migraine: a descriptive study. J Manipulative Physiol Ther
1992;15:418–29.
81. Kidd RF, Nelson R. Musculoskeletal dysfunction of the neck in
migraine and tension headache. Headache 1993;33: 566–9.
82. Wight JS. Migraine: a statistical analysis of chiropractic treatment.
ACA J Chiropractic 1978;12S:63–7.
83. Stodolny J, Chmielewski H. Manual therapy in the treatment of
patients with cervical migraine. Man Med 1989;4:49–51.
84. Tuchin PJ. A twelve month clinical trial of chiropractic spinal
manipulative therapy for migraine. ACO 1999;8(2):61–5.
85. Parker GB, Tupling H. Pryor D. A controlled trial of manipulation for
migraine. Aust NZ J Med 1978;8:589–93.
86. Parker GB, Tupling H, Pryor D. Why does migraine improve during a
clinical trial? Further results from a trial of cervical manipulation for migraine. Aust
NZ J Med 1980;10:192–8.
87. Tuchin P, Pollard H, Bonello R. A randomized controlled trial of
chiropractic spinal manipulative therapy for migraine. J Manipulative Physiol Ther
2000;23:91–5.
88. Nelson CF, Bronfort G, Evans R, et al. The efficacy of spinal
manipulation, amitripyline and the combination of both therapies for the prophylaxis of
migraine headache. J Manipulative Physiol Ther 1998;21:511–8.